MedRhythms Announces InTandem™ is Now Available by Prescription for Adults with Chronic Stroke Walking Impairment

2023-10-16
Visit the InTandem booth at the American Congress of Rehabilitation Medicine (ACRM) 2023 Annual Conference Expo in Atlanta, GA
PORTLAND, Maine, Oct. 16, 2023 /PRNewswire/ -- MedRhythms today announced that InTandem (MR-001) is now available by prescription for at-home use to improve walking and ambulation in adults living with chronic stroke walking impairments. InTandem is an evidence-based neurorehabilitation system based on the principles of Rhythmic Auditory Stimulation (RAS), an established and standardized intervention utilizing the mechanism of action of auditory-motor entrainment. Entrainment occurs when the motor and auditory systems in the brain unconsciously synchronize to an external cue, such as music.
MedRhythms Announces InTandem™ is Now Available by Prescription for Adults with Chronic Stroke Walking Impairment
Preview
来源: PRNewswire
InTandem™ includes shoe-worn sensors, a headset, and a touchscreen device preloaded with the InTandem software
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。